FADS2 and bladder transitional cell carcinoma: There was a significant increase in FADS2 mRNA expression in most types of cancer, such as UCEC, COAD, KIRC, BRCA, LUSC, HNSC, LIHC, and bladder urothelial carcinoma (BLCA) (Fig. 1C).